Hot Pursuit     15-Feb-24
Biocon Ltd rises for third straight session
Biocon Ltd is quoting at Rs 274.6, up 1.07% on the day as on 12:49 IST on the NSE. The stock is up 13.07% in last one year as compared to a 21.22% jump in NIFTY and a 51.05% jump in the Nifty Pharma index.

Biocon Ltd is up for a third straight session today. The stock is quoting at Rs 274.6, up 1.07% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.11% on the day, quoting at 21863.25. The Sensex is at 71855.64, up 0.05%. Biocon Ltd has slipped around 4.52% in last one month.

Meanwhile, Nifty Pharma index of which Biocon Ltd is a constituent, has slipped around 7.25% in last one month and is currently quoting at 18584.35, down 0.04% on the day. The volume in the stock stood at 28.2 lakh shares today, compared to the daily average of 72.65 lakh shares in last one month.

The benchmark February futures contract for the stock is quoting at Rs 275.35, up 0.86% on the day. Biocon Ltd is up 13.07% in last one year as compared to a 21.22% jump in NIFTY and a 51.05% jump in the Nifty Pharma index.

The PE of the stock is 0 based on TTM earnings ending December 23.

Previous News
  Market at day’s high; VIX climbs 3.96%; realty shares advance
 ( Market Commentary - Mid-Session 18-Apr-24   12:37 )
  Stock Alert: Indegene, Wipro, Biocon, HUDCO
 ( Market Commentary - Stock Alert 13-May-24   08:28 )
  Biocon gets US FDA nod for fungal infection drug
 ( Hot Pursuit - 04-Jun-24   11:18 )
  Biocon Ltd eases for fifth straight session
 ( Hot Pursuit - 12-Jul-24   13:36 )
  Biocon gets nod from SAHPRA for Tacrolimus capsules
 ( Hot Pursuit - 20-Apr-24   15:36 )
  Biocon Ltd soars 2.25%, up for fifth straight session
 ( Hot Pursuit - 11-Jun-24   13:00 )
  Biocon Ltd soars 1.22%, rises for fifth straight session
 ( Hot Pursuit - 27-Mar-24   13:00 )
  Biocon consolidated net profit rises 167.80% in the September 2023 quarter
 ( Results - Announcements 10-Nov-23   17:28 )
  Biocon consolidated net profit declines 29.78% in the June 2023 quarter
 ( Results - Announcements 11-Aug-23   07:47 )
  Biocon inks pact with Juno Pharma for commercialization of Liraglutide
 ( Hot Pursuit - 09-Oct-23   10:11 )
  Biocon receives Complete Response Letter for Biologics License Application
 ( Corporate News - 09-Feb-24   09:11 )
Other Stories
  Lupin receives EIR from USFDA for Dabhasa facility
  13-Jul-24   16:48
  RVNL secures LoA worth Rs 132 cr from Central Railway
  13-Jul-24   16:38
  EMS bags order worth Rs 141-cr from Uttarakhand Power Corp.
  13-Jul-24   16:14
  Avenue Supermarts Q1 PAT climbs 17% YoY to Rs 774 cr in FY25
  13-Jul-24   16:00
  Sunteck Realty pre-sales climbs 30% YoY to Rs 502 cr in FY25
  13-Jul-24   15:32
  Fitch Ratings revises outlook on ratings of Tata Steel to 'negative'
  13-Jul-24   14:46
  5Paisa Capital Q1 PAT jumps 38% YoY in FY25
  13-Jul-24   14:39
  HCL Tech records PAT of Rs 4,257 crore in Q1; EBIT margin at 17.1%
  13-Jul-24   11:59
  IREDA Q1 PAT rises 30% YoY to Rs 384 cr in FY25
  13-Jul-24   09:00
  GTPL Hathway slides after Q1 PAT drops 60% YoY to Rs 14 cr in FY25
  12-Jul-24   15:40
Back Top